High Throughput Screening Market, By Product and Services (Reagents & Assay Kits, Instruments, Consumables & Accessories, and Software and Services), By Technology (Cell-Based Assays, 2D Cell Culture, 3D Cell Culture (Scaffold-Based Technologies (Hydrogels, Inert Matrix, and Micropatterned Surfaces) and Scaffold-Free Technologies (Microplate, Hanging-Drop Plates, Ultra-Low Binding Plates, and Other Scaffold-Free Technologies)) Perfusion Cell Culture, Lab-On-A-Chip (LOC), Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology), By Application (Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, and Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, and Other End User), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI54919 | Publish Date: April 2024 | No. of Pages: 180

Global High Throughput Screening Market Overview

High throughput screening (HTS) is a drug discovery technique employed for screening and evaluation of large number of biological modulators and effectors against selected target and are routinely used in toxicology studies and stem cell research. It is used to test environmental chemicals, drugs, and formulations for in-depth toxicological evaluation and the development of disease-associated and predictive toxicological pathways. Miniaturization can identify toxic compounds early in the process of drug discovery, thereby saving enormous financial resources. Over last two decade, high throughput screening has gained a widespread popularity and has become a standard method of drug discovery in the pharmaceutical industry. The increased utilization of the HTS technique in the field of toxicology will prove to be beneficial in the long run. High throughput screening market accounted for US$ 15.46 billion in 2020 and is estimated to be US$ 31.79 billion by 2030 and is anticipated to register a CAGR of 7.5%.

Introduction - High Throughput Screening Market

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global High Throughput Screening Market Dynamics

Demand for the global high throughput screening

Increasing capital investment in high throughput screening technology by research organizations and key players operating in market has accelerated the growth and demand for the global high throughput screening market in past one decade. Label free methods, automation & miniaturization of technique and growth of contract research organizations in emerging market have further escalated the demand and procurement of instruments across the globe. However, academic research laboratories find it difficult to afford such instruments, as they have restricted budgets. In addition, high capital requirement for initial set up and maintenance cost are among the major restraints hampering the growth of the target market. Well, growing economy are among the prominent drivers escalating growth of high throughput screening market in emerging economic countries.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global High Throughput Screening Market Segmentation

High throughput screening market is segmented into product and services, technology, application, end user and, region.

Based on product and services, the high throughput screening market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. Based on technology, the global high throughput screening market is segmented into cell-based assay, 2d cell culture, 3d cell culture, perfusion cell culture, lab-on-a-chip(LOC), ultra-high-throughput screening, bioinformatics, and label free technology. 3D cell culture is subdivided into scaffold-based technologies and scaffold-free technologies. Scaffold-based technologies is subdivided into hydrogels, inert matrix, and micropatterned surfaces. Scaffold-free technologies is subdivided into microplate, hanging-drop plates, ultra-low binding plate, and other scaffold-free technologies. Based on application, the global high throughput screening market is segmented into target identification & validation, primary and secondary screening, toxicology assessment, and other applications. Based on end user, the global high throughput screening is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations, and other end user.

Regional Insights:

High throughput screening market accounted for US$ 15.46 billion in 2020 and is estimated to be US$ 31.79 billion by 2030 and is anticipated to register a CAGR of 7.5%. Based on the region the global high throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global high throughput screening market due to increasing geriatric population. Asia Pacific global high throughput screening market is projected to register a high CAGR over the forecast period owing to the increasing trend of artificial intelligence & machine learning fuels the growth of the market. Furthermore, faster data processing and rise in automation in the field of high throughput screening boost the growth of target market

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Product and services- Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, Services

By Technology – Cell-Based Assays, 2D Cell Culture, 3D Cell Culture (Scaffold-Based Technologies (Hydrogels, Inert Matrix, and Micropatterned Surfaces) and Scaffold-Free Technologies (Microplate, Hanging-Drop Plates, Ultra-Low Binding Plates, and Other Scaffold-Free Technologies)) Perfusion Cell Culture, Lab-On-A-Chip (LOC), Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology)

By Application– Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, and Other Applications

By End-user- Pharmaceutical And Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, and Other End User

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global high throughput screening market report based on product and service, Technology, application, End-user and region.

Regional Insights - High Throughput Screening Market

Global high throughput screening Market, By Region:

  • North America
      • Middle East & Africa
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • U.S.
      • Canada

Global High Throughput Screening Market Key Players

The key players operating the high throughput screening market involves Agilent Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Perkinelmer Inc., Thermo Fisher Scientific Inc., Danaher, Tecan Group, Axxam, Bio-Rad and Hamilton Company.  Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market.

Global High Throughput Screening Market Company Profile

  • Agilent Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PerkinElmer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Tecan Group
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Axxam
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Hamilton Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global High Throughput Screening Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product and services
      • Market Snippet, By technology
      • Market Snippet, By Application
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Product and services, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Reagents & Assay Kits
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Instruments
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Consumables & Accessories
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Software and Services
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By technology, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Cell-Based Assays
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • 2D Cell Culture
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • 3D Cell Culture
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Scaffold-Based Technologies (Hydrogels, Inert Matrix, and Micropatterned Surfaces)
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Scaffold-Free Technologies (Microplate, Hanging-Drop Plates, Ultra-Low Binding Plates, and Other Scaffold-Free Technologies)
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Perfusion Cell Culture, Lab-On-A-Chip (LOC), Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Target Identification & Validation
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Primary and Secondary Screening
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Toxicology Assessment
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Other Applications
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End-Users , Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Pharmaceutical And Biotechnology Companies
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Academic and Government Institutes
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Other End Users
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Product and services, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Product and services, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Product and services, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Product and services, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Product and services, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  2. Company Profiles
  • Agilent Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PerkinElmer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Tecan Group
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Axxam
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Hamilton Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

The global high throughput screening market is segmented based on product and services, technology , application, End-user and region.

Increasing capital investment in high throughput screening technology by research organizations and key players operating in market has accelerated the growth and demand for the global high throughput screening market in past one decade.

The market in North America accounts highest revenue share to the global high throughput screening market due to increasing geriatric population

The key players operating the global high throughput screening market involves Agilent Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Perkinelmer Inc., Thermo Fisher Scientific Inc., Danaher, Tecan Group, Axxam, Bio-Rad and Hamilton Company.